We are live on ! Find out more
ZVRA icon

Zevra Therapeutics
ZVRA

120 hedge funds and large institutions have $319M invested in Zevra Therapeutics in 2025 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 45 increasing their positions, 29 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

85% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 13

55% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 29

17% more capital invested

Capital invested by funds: $272M → $319M (+$47.4M)

9% more funds holding

Funds holding: 110 → 120 (+10)

0.64% more ownership

Funds ownership: 65.55% → 66.19% (+0.64%)

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

14% less call options, than puts

Call options by funds: $5.01M | Put options by funds: $5.81M

Holders
120
Holders Change
+10
Holders Change %
+9.09%
% of All Funds
1.58%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
24
Increased
45
Reduced
29
Closed
13
Calls
$5.01M
Puts
$5.81M
Net Calls
-$793K
Net Calls Change
+$1.51M

Top Buyers

Rank Fund Capital Flow
1
RCMNY
Rubric Capital Management (New York)
New York
+$6.01M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$4.46M
3
Millennium Management
Millennium Management
New York
+$4.27M
4
KCM
Kingdon Capital Management
New York
+$3.65M
5
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$2.56M

Top Sellers

Rank Fund Capital Flow
1
RAM
Readystate Asset Management
Illinois
-$4.64M
2
ACM
AIGH Capital Management
Maryland
-$4.21M
3
JGC
J. Goldman & Co
New York
-$3.1M
4
Barclays
Barclays
United Kingdom
-$2.68M
5
Citadel Advisors
Citadel Advisors
Florida
-$1.09M
Name Holding Trade Value Shares
Change 		Change in
Stake
IA
101
IFP Advisors
Florida
$5.08K – – –
Carson Wealth (CWM LLC)
102
Carson Wealth (CWM LLC)
Nebraska
$5K +$730 +90 +19%
CIAM
103
Caitong International Asset Management
Hong Kong
$4.56K -$625 -77 -13%
BI
104
Binnacle Investments
Iowa
$4.06K -$1.52K -187 -29%
CIBC Private Wealth Group
105
CIBC Private Wealth Group
Georgia
$3.96K – – –
LFG
106
Larson Financial Group
Missouri
$3.46K +$2.3K +283 +257%
GI
107
GAMMA Investing
California
$2.55K -$6.39K -787 -73%
PD
108
Point72 (DIFC)
United Arab Emirates
$2.33K +$2.14K +264 New
MPWT
109
MassMutual Private Wealth & Trust
Connecticut
$2.25K +$852 +105 +70%
Daiwa Securities Group
110
Daiwa Securities Group
Japan
$2K – – –
API
111
Asset Planning Inc
California
$1.89K – – –
SCM
112
Sterling Capital Management
North Carolina
$1.15K -$2.9K -358 -73%
National Bank of Canada
113
National Bank of Canada
Quebec, Canada
$828 +$763 +94 New
RIL
114
Rothschild Investment LLC
Illinois
$793 -$243 -30 -25%
KG
115
Kilter Group
New York
$793 +$730 +90 New
PFBT
116
Parkside Financial Bank & Trust
Missouri
$529 +$487 +60 New
CFD
117
Creative Financial Designs
Indiana
$493 – – –
AF
118
Allworth Financial
California
$221 +$203 +25 New
MCM
119
MAI Capital Management
Ohio
$106 – – –
EWA
120
EverSource Wealth Advisors
Alabama
$88 -$32 -4 -29%
JWA
121
JFS Wealth Advisors
Pennsylvania
$18 – – –
ACM
122
Altium Capital Management
New York
– -$9.64M -1,287,333 Closed
Squarepoint
123
Squarepoint
New York
– -$510K -68,050 Closed
ECM
124
ExodusPoint Capital Management
New York
– -$314K -41,932 Closed
EC
125
EntryPoint Capital
New York
– -$305K -40,675 Closed
2 3 4
5
6

ZVRA Hedge Fund Activity: Q2 2025 in Review

120 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Zevra Therapeutics (ZVRA) for Q2 2025, worth a combined $319M — up 17% from $272M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new ZVRA positions and 13 closed out — a net gain of 11 holders — while 45 added to existing stakes and 29 trimmed.

The largest buyer was Rubric Capital Management (New York), adding an estimated $6.01M. The largest seller was Readystate Asset Management, cutting an estimated $4.64M.

  • 120 institutional investors held Zevra Therapeutics (ZVRA) as of Q2 2025, up from 110 in Q1 2025.
  • Funds reported $319M of Zevra Therapeutics stock for Q2 2025, up 17% quarter-over-quarter.
  • 24 funds opened new Zevra Therapeutics positions in Q2 2025 and 13 closed out, a net change of +11 holders.
  • The largest Zevra Therapeutics buyer in Q2 2025 was Rubric Capital Management (New York), an estimated $6.01M added.
  • The largest Zevra Therapeutics seller in Q2 2025 was Readystate Asset Management, an estimated $4.64M sold.

Based on aggregated 13F filings for Q2 2025.